Boehringer Ingelheim Pharma GmbH & Co. KG (Manufacturer (lyophilizate): full-cycle manufacturing (including production, critical manufacturing control, quality control in studies for batch release (all parameters), quality control in stability studies (all parameters), primary packaging, secondary packaging, batch release); Manufacturer (solvent, water for injections): full-cycle manufacturing (production (including in-process quality control), final product quality control (for batch release and stability studies), primary labeling, secondary packaging and labeling, batch release))

Ukraine

All drugs from this manufacturer

  • ACTILISE®

    The drug is used for thrombolytic treatment in acute myocardial infarction, acute massive pulmonary embolism with hemodynamic instability, and acute ischemic stroke.

    Dosage form: powder for solution for infusion

    Active substance Dosage
    alteplase 50 mg

    ATC: B01AD02